Veterinary Rapid Test Market Report 2026

Veterinary Rapid Test Market Overview

• Veterinary Rapid Test market size has reached to $0.89 billion in 2025 • Expected to grow to $1.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: The Impact Of Rising Pet Ownership On The Veterinary Rapid Test Market • Market Trend: Revolutionizing Veterinary Diagnostics With The Emergence of AI-Based Rapid Tests In Veterinary Healthcare • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Rapid Test Market?

A veterinary rapid test is a diagnostic tool used in veterinary medicine to quickly detect the presence of specific pathogens, diseases, or conditions in animals. These tests are designed to provide fast and accurate results, often within minutes to a few hours, allowing for timely decision-making in the treatment and management of animal health. Veterinary rapid tests play a crucial role in animal healthcare by enabling prompt diagnosis and treatment, improving outcomes, and aiding in controlling and preventing disease spread among animal populations. The main product types of veterinary rapid tests are rapid test kits and rapid test readers. Veterinary rapid test kits are specialized tools used for screening animals like cats, dogs, cattle, and bovines by placing a sample of a specimen on a device. The various animal types include companion animals, and production animals using various technologies such as immunoassays, and polymerase chain reaction (PCR). These are used in various applications such as viral diseases, bacterial diseases, parasitic diseases, allergies, and others, and also by various end-users such as veterinary hospitals and clinics, home care settings, and others.

What Is The Veterinary Rapid Test Market Growth Forecast?

The veterinary rapid test market size is expected to see rapid growth in the next few years. It will grow to $1.46 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to advancements in molecular and immunoassay technologies, rising demand for on-site diagnostic solutions, expansion of livestock farming and intensive animal production, increasing focus on early disease detection, growing investment in veterinary diagnostics innovation. Major trends in the forecast period include growing demand for point-of-care diagnostics, rising adoption of rapid tests for infectious disease screening, increasing use of portable and handheld diagnostic devices, expansion of preventive and routine animal health testing, preference for user-friendly and time-efficient diagnostic solutions.

Global Veterinary Rapid Test Market Segmentation

1) By Product: Rapid Test Kits, Rapid Test Readers 2) By Animal Type : Companion Animal, Production Animal 3) By Technology: Immunoassays, Polymerase Chain Reaction(PCR) 4) By Application: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Allergies, Other Applications 5) By End-User: Veterinary Hospitals And Clinics, Homecare Settings, Other End Users Subsegments: 1) By Rapid Test Kits: Immunoassay-based Kits, Lateral Flow Assays, Enzyme-linked Immunosorbent Assay (ELISA) Kits, Molecular Diagnostic Kits 2) By Rapid Test Readers: Portable Readers, Bench-Top Readers

What Is The Driver Of The Veterinary Rapid Test Market?

The increasing pet ownership is expected to propel the growth of the growth of the veterinary rapid test market going forward. Pet ownership refers to the relationship in which an individual or household takes responsibility for a pet animal's care, welfare, and maintenance. The increasing pet ownership is rising due to a growing recognition of the mental health benefits that pets provide, such as reducing stress and offering companionship. Increasing pet ownership supports veterinary rapid testing by driving higher demand for frequent, convenient, and early diagnostic screening as more pet owners seek timely, affordable, and preventive healthcare solutions to maintain their animals’ health and well-being. For instance, in April 2025, according to the Canadian Animal Health Institute, a Canada-based trade association, in 2024, Canada was home to an estimated 7.2 million dogs and 8.2 million cats, making pets an integral part of more than half of Canadian households. Therefore, increasing pet ownership drives the veterinary rapid test industry.

Key Players In The Global Veterinary Rapid Test Market

Major companies operating in the veterinary rapid test market are Thermo Fisher Scientific Inc., Zoetis Inc., bioMérieux SA, IDEXX Laboratories Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN GmbH, Virbac Corp., Neogen Corporation, Antech Diagnostics Inc., Heska Corporation, Ring Biotechnology Co Ltd., BioChek, Bionote USA Inc., Agrolabo S.p.A., Shenzhen Bioeasy Biotechnology Co. Ltd., Fassisi GmbH, MEGACOR Diagnostik GmbH, Biopanda Reagents Ltd., Boster Biological Technology Co. Ltd., Secure Diagnostics Pvt. Ltd., Eurolyser Diagnostica GmbH

Global Veterinary Rapid Test Market Trends and Insights

Major companies operating in the veterinary rapid test market are developing advanced solutions such as AI-based rapid tests to enhance diagnostic accuracy and improve overall efficiency in veterinary healthcare. AI-based rapid tests represent a significant advancement in veterinary diagnostics, offering veterinarians powerful tools to expedite the diagnostic process, improve diagnostic accuracy, and ultimately enhance the quality of care provided to animals. For instance, in November 2023, Micron Agritech, an Ireland-based sustainable health company, launched the Micron Kit Fluke Test, an innovative AI-powered rapid test for liver fluke in livestock. This breakthrough solution allows farmers and veterinarians to quickly test animals on-site using their smartphones for both liver fluke (Fasciola hepatica) and rumen fluke (Calicophoron daubneyi) infections

What Are Latest Mergers And Acquisitions In The Veterinary Rapid Test Market?

In September 2023, Mars Incorporated, a US-based multinational manufacturing and animal care company, acquired SYNLAB Vet for an undisclosed amount. With this acquisition, Mars aimed to strengthen and broaden its veterinary diagnostics and technology capabilities in Europe, expand its R&D footprint, and enhance access to pet healthcare solutions across veterinary professionals and pet owners. SYNLAB Vet is a Germany-based healthcare technology company that specializes in providing specialist veterinary laboratory diagnostic services and comprehensive diagnostic technologies to veterinary professionals and clinics across Europe.

Regional Outlook

North America was the largest region in the veterinary rapid test market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Rapid Test Market?

The veterinary rapid test market consists of sales of canine tests, feline tests, equine tests, and livestock tests. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.